AbbVie (ABBV) Price to Sales (2013 - 2026)
AbbVie's Price to Sales was 6.91 in Q2 2026, up 22.9% from 5.62 a year earlier and up 12.9% from the prior quarter.
Analysis
AbbVie (ABBV) Price to Sales (2013 - 2026) Analysis & Trends
For FY2025, Price to Sales at AbbVie came in at 6.61, up 18.6% from FY2024.
- Price to Sales has now increased for six consecutive years.
- In earlier years, Price to Sales was 5.57 in FY2024 (+10.5%), 5.04 in FY2023 (+2.3%), 4.93 in FY2022 (+15.6%) and 4.26 in FY2021 (+3.2%).
- The Q2 2026 figure marks the highest quarterly Price to Sales in data going back to Q1 2013.
- Compared with a year earlier, Price to Sales was higher in seven of the last eight quarters, with growth averaging 12.4%.
- The best year-over-year quarter for Price to Sales over five years was Q1 2022 (growth of 32.6%); the worst was Q2 2023 (a decline of 10.1%).
- Per Business Quant data, ABBV's Price to Sales in the three quarters before Q2 2026 was 6.12 (Q1 2026), 6.61 (Q4 2025) and 6.86 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.91 |
| Mar 31, 2026 | 6.12 |
| Dec 31, 2025 | 6.61 |
| Sep 30, 2025 | 6.86 |
| Jun 30, 2025 | 5.62 |
| Mar 31, 2025 | 6.45 |
| Dec 31, 2024 | 5.57 |
| Sep 30, 2024 | 6.28 |
| Jun 30, 2024 | 5.51 |
| Mar 31, 2024 | 5.91 |
| Dec 31, 2023 | 5.04 |
| Sep 30, 2023 | 4.77 |
| Jun 30, 2023 | 4.24 |
| Mar 31, 2023 | 4.96 |
| Dec 31, 2022 | 4.93 |
| Sep 30, 2022 | 4.11 |
| Jun 30, 2022 | 4.72 |
| Mar 31, 2022 | 5.05 |
| Dec 31, 2021 | 4.26 |
| Sep 30, 2021 | 3.46 |
API Access
AbbVie Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();